List of Artificial Intelligence Companies in Denmark - 6

Cellari enables doctors and non-specialists to take full advantage of recent developments in artificial intelligence. Cellari aims to provide the most precise "active learning model" for biological image segmentation combined with an intuitive and easy-to-use user interface for carrying out complex image related tasks and analytics. An automated statistical testing service ensures statistical validity of clinical and research related results along with unparalleled review and methodology transparency functionalities. Cellari is a proud part of the InnoFounder – Graduate incubator for Cohort 5 of September 2019.

Evaxion Biotech A/S, a clinical-stage artificial intelligence-immunology platform company, identifies and develops novel immunotherapies for the treatment of various cancers, bacterial diseases, and viral infections. The company develops therapies using PIONEER, an immuno-oncology platform; EDEN, a bacterial disease platform; and RAVENTM, a viral disease platform. It develops EVX-01, a novel liposomal, peptide-based cancer immunotherapy that is in clinical Phase I/IIa trial for indications, such as metastatic and/or unresectable melanoma, non-small cell lung cancer, and bladder cancer; EVX-02, a novel, DNA-based cancer immunotherapy that is in Phase I/IIa trial designed to induce a therapeutic immune response in the adjuvant setting in patients with resected melanoma; and EVX-03, a DNA-based neoepitope immunotherapy, which is in late pre-clinical development for the treatment of various cancers, as well as EVX-B1, a multi-component subunit vaccine for the prevention of S. aureus induced skin and soft tissue infections in patients undergoing hernia surgery. The company has collaboration agreements with National Center for Cancer Immune Therapy (CCIT-DK) at Herlev Hospital, Department of Health Technology at Danish Technical University, Center for Genomic Medicine at University Hospital Copenhagen, and the Center for Vaccine Research at SSI for the development and Phase 1/2a clinical trial of its EVX-01 product candidate. Evaxion Biotech A/S was founded in 2008 and is headquartered in Copenhagen, Denmark.

Reshape Biotech is building the next generation of lab automation robots. Our customers are biotech companies tackling the world’s biggest problems - be it alternative protein development or sustainable agriculture. Reshape Biotech is the scaling factor for these companies, as we let researchers collaborate globally on experiments and increase their throughput >500x. The team is highly multi-disciplinary, employing everything from PhD’s in biology to hardware and software engineers. We work closely together, and you will be exposed to a truly vertical team. We’re a fast growing startup with an incredibly ambitious team, dead-set on reinventing a 100 year old industry and becoming the standard infrastructure that the world of biotech relies on. Our customers already include global leaders in food, agriculture and biologicals. We’re backed by top tier investors from Y Combinator, CEOs from the industry and some of the biggest names you can find. At Reshape Biotech, you have the potential to influence how biotech research is done in the next 100 years.

At Synamics Therapeutics, our innovative strategy is not just about treating cancer—it's about staying one step ahead. The heart of our approach lies in our sophisticated AI-driven resistance modeling. This allows us to not only confront existing cancer mutations but also to proactively anticipate and target potential future mutations. By predicting these future resistance pathways, our AI model guides the design of our small molecules to effectively combat evolving cancer threats. This forward-thinking approach ensures the sustained efficacy of our therapies, significantly enhancing patient outcomes and leading the way in the evolution of precision oncology.

Tailwind Biotech is a biotech company offering synthetic DNA design services for improved strain development. We use proprietary Artificial Intelligence to help bioproduction-based companies worldwide achieve more effective and more efficient genetic engineering processes. Our technology designs optimized DNA sequences that help to maximize biological manufacturing yields while reducing development costs. We believe that by leveraging the powerful mix of Artificial Intelligence and Synthetic Biology, we can accelerate advancements in healthcare, agriculture, sustainable energy and beyond.

We are a leading provider of AI-driven precision pathology software for research and diagnostics. In research, we are a technology leader providing tools that help scientists, pathologists, and image analysis experts produce accurate data for all types of tissue-based research. In diagnostics, we are a leader within clinical applications, with no less than eight diagnostic algorithms cleared under IVDR for EU customers. These applications provide diagnostic decision support and and can be easily activated and integrated into existing lab workflows. Founded in 2002, we are privately owned and operate internationally with over 750 customer accounts in more than 40 countries. Our company’s headquarters are located in Denmark’s Medicon Valley, with offices in Sweden, the UK, Germany, the Netherlands, and the United States, and local representation in France and China.